TRxADE Health and Scienture to close Business Combination Transaction Valued at $103 Million
DENVER, Colo., Jul 26, 2024 (247marketnews.com)- TRxADE HEALTH, INC. (Nasdaq:MEDS) and Scienture, Inc. are closing their business combination in an all-stock transaction valued at $103 million, in which TRxADE acquired all of Scienture’s assets in exchange for shares of TRxADE stock, resulting in a combined company that will focus on bringing specialty pharmaceutical products to market.
Scienture’s President and CEO, Shankar Hariharan, stated, We are very excited about the merger and believe the new combined company will provide the vehicle for our future expansion.
“Our mission at Scienture is in developing unique specialty product concepts and solutions that bring enhanced value to patients, caregivers and healthcare systems. Our assets in development are across therapeutics areas, indications and cater to different market segments. We are committed to serving patients, physicians and other healthcare stakeholders to attain better health outcomes.”
About 24/7 Market News
As a pioneer in digital financial market media, 24/7 Market News (24/7MN) is dedicated to the swift distribution of financial market news and information. 24/7 MN incorporates comprehensive corporate communications resources and tools to engage the investment community. Visit 24/7 Market News website here.
24/7 MARKET NEWS, INC Disclaimer
Please go to https://247marketnews.com/disclaimer/ for disclaimer information.
CONTACT:
24/7 Market News
Editor@247marketnews.com